• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

In-Stent Restenosis? The Raiders of the Magic Remedy.

作者信息

Waksman Ron, Steinvil Arie

机构信息

From the Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC.

出版信息

Circ Cardiovasc Interv. 2016 Jul;9(7). doi: 10.1161/CIRCINTERVENTIONS.116.004150.

DOI:10.1161/CIRCINTERVENTIONS.116.004150
PMID:27412872
Abstract
摘要

相似文献

1
In-Stent Restenosis? The Raiders of the Magic Remedy.支架内再狭窄？神奇疗法的探索者。
Circ Cardiovasc Interv. 2016 Jul;9(7). doi: 10.1161/CIRCINTERVENTIONS.116.004150.
2
Restenosis in a Bare-Metal Stent: Drug-Eluting Balloon or Drug-Eluting Stent?裸金属支架再狭窄：药物洗脱球囊还是药物洗脱支架？
Circ Cardiovasc Interv. 2016 Apr;9(4):e003829. doi: 10.1161/CIRCINTERVENTIONS.116.003829.
3
A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).药物洗脱球囊与依维莫司洗脱支架治疗金属裸支架内再狭窄的随机对照研究：RIBS V 临床试验（金属裸支架内再狭窄：紫杉醇洗脱球囊与依维莫司洗脱支架）。
J Am Coll Cardiol. 2014 Apr 15;63(14):1378-86. doi: 10.1016/j.jacc.2013.12.006. Epub 2014 Jan 8.
4
Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.西罗莫司洗脱支架或紫杉醇洗脱支架与球囊血管成形术预防冠状动脉支架内再狭窄患者复发的随机对照试验。
JAMA. 2005 Jan 12;293(2):165-71. doi: 10.1001/jama.293.2.165.
5
A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.药物洗脱球囊联合裸金属支架与裸金属支架与药物洗脱支架治疗分叉病变的单支架技术的多中心随机对照比较：分叉病变中药物洗脱球囊的 6 个月血管造影和 12 个月临床结果研究。
Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1138-46. doi: 10.1002/ccd.23499. Epub 2012 Mar 15.
6
Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.光学相干断层扫描（OCT）在经皮冠状动脉介入治疗（PCI）中的支架内再狭窄（ISR）：SEDUCE 研究（药物洗脱球囊在冠状动脉再狭窄中的安全性和疗效）的原理和设计。
EuroIntervention. 2011 May;7 Suppl K:K100-5. doi: 10.4244/EIJV7SKA17.
7
Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.裸金属支架置入术后基于导管的紫杉醇给药与药物洗脱支架在冠状动脉疾病支架内再狭窄高危患者中的比较。
Cardiovasc Revasc Med. 2017 Dec;18(8):596-600. doi: 10.1016/j.carrev.2017.05.018. Epub 2017 May 31.
8
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.紫杉醇涂层球囊导管与紫杉醇涂层支架治疗冠状动脉支架内再狭窄：PEPCAD II ISR研究的三年结果
EuroIntervention. 2015 Dec;11(8):926-34. doi: 10.4244/EIJY14M08_12.
9
Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.紫杉醇洗脱支架与血管内近距离放射治疗用于裸金属支架内支架再狭窄的比较：TAXUS V ISR随机试验
JAMA. 2006 Mar 15;295(11):1253-63. doi: 10.1001/jama.295.11.1253. Epub 2006 Mar 12.
10
A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.紫杉醇涂层球囊血管成形术与普通球囊血管成形术治疗药物洗脱支架再狭窄的随机、多中心、单盲临床试验：PEPCAD-DES 研究。
J Am Coll Cardiol. 2012 Apr 10;59(15):1377-82. doi: 10.1016/j.jacc.2012.01.015. Epub 2012 Feb 29.

引用本文的文献

1
Artesunate Inhibits Neointimal Hyperplasia by Promoting IRF4 Associated Macrophage Polarization.青蒿琥酯通过促进与IRF4相关的巨噬细胞极化来抑制内膜增生。
Adv Sci (Weinh). 2025 May;12(19):e2408992. doi: 10.1002/advs.202408992. Epub 2025 Mar 24.
2
A novel glycyrrhizin acid-coated stent reduces neointimal formation in a rabbit iliac artery model.一种新型甘草次酸涂层支架可减少兔髂动脉模型中的内膜增生。
Front Pharmacol. 2023 May 17;14:1159779. doi: 10.3389/fphar.2023.1159779. eCollection 2023.
3
Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis.
药物涂层球囊血管成形术后支架内再狭窄患者靶病变再狭窄的发生率及影响因素分析。
BMC Cardiovasc Disord. 2022 Nov 20;22(1):493. doi: 10.1186/s12872-022-02923-z.
4
Highly Selective PPARα (Peroxisome Proliferator-Activated Receptor α) Agonist Pemafibrate Inhibits Stent Inflammation and Restenosis Assessed by Multimodality Molecular-Microstructural Imaging.高选择性过氧化物酶体增殖物激活受体 α（PPARα）激动剂 pemafibrate 通过多模态分子-微观结构成像评估抑制支架炎症和再狭窄。
J Am Heart Assoc. 2021 Oct 19;10(20):e020834. doi: 10.1161/JAHA.121.020834. Epub 2021 Oct 11.
5
Surface engineering at the nanoscale: A way forward to improve coronary stent efficacy.纳米尺度的表面工程：提高冠状动脉支架疗效的前进之路。
APL Bioeng. 2021 Jun 1;5(2):021508. doi: 10.1063/5.0037298. eCollection 2021 Jun.
6
Platelet-Derived Extracellular Vesicles Increase Col8a1 Secretion and Vascular Stiffness in Intimal Injury.血小板衍生的细胞外囊泡增加内膜损伤中的Col8a1分泌和血管硬度。
Front Cell Dev Biol. 2021 Mar 2;9:641763. doi: 10.3389/fcell.2021.641763. eCollection 2021.
7
In-stent restenosis and longitudinal stent deformation: a case report.支架内再狭窄和支架纵向变形：一例报告。
BMC Cardiovasc Disord. 2020 Jan 17;20(1):24. doi: 10.1186/s12872-020-01335-1.
8
Refractory In-Stent Restenosis: Improving Outcomes by Standardizing Our Approach.难治性支架内再狭窄：通过标准化治疗方法改善结局。
Curr Cardiol Rep. 2018 Oct 22;20(12):140. doi: 10.1007/s11886-018-1076-6.
9
Diagnosis and management challenges of in-stent restenosis in coronary arteries.冠状动脉支架内再狭窄的诊断与管理挑战
World J Cardiol. 2017 Aug 26;9(8):640-651. doi: 10.4330/wjc.v9.i8.640.